327 related articles for article (PubMed ID: 24184935)
1. Proximal fluid proteomics for the discovery of digestive cancer biomarkers.
Farina A
Biochim Biophys Acta; 2014 May; 1844(5):988-1002. PubMed ID: 24184935
[TBL] [Abstract][Full Text] [Related]
2. Inconvenient truth: cancer biomarker development by using proteomics.
Kondo T
Biochim Biophys Acta; 2014 May; 1844(5):861-5. PubMed ID: 23896458
[TBL] [Abstract][Full Text] [Related]
3. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers.
Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D
Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727
[TBL] [Abstract][Full Text] [Related]
4. Proteomics analysis of bodily fluids in pancreatic cancer.
Pan S; Brentnall TA; Chen R
Proteomics; 2015 Aug; 15(15):2705-15. PubMed ID: 25780901
[TBL] [Abstract][Full Text] [Related]
5. The gastric fluid proteome as a potential source of gastric cancer biomarkers.
Wu W; Chung MC
J Proteomics; 2013 Sep; 90():3-13. PubMed ID: 23665003
[TBL] [Abstract][Full Text] [Related]
6. Biomarker research with prospective study designs for the early detection of cancer.
Pesch B; Brüning T; Johnen G; Casjens S; Bonberg N; Taeger D; Müller A; Weber DG; Behrens T
Biochim Biophys Acta; 2014 May; 1844(5):874-83. PubMed ID: 24361552
[TBL] [Abstract][Full Text] [Related]
7. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
[TBL] [Abstract][Full Text] [Related]
8. [Proteomic analysis of protein profiles in some pathological stages of the human organism].
Kossowska B; Dudka I; Gancarz R; Antonowicz-Juchniewicz J
Postepy Hig Med Dosw (Online); 2009 Nov; 63():549-63. PubMed ID: 19940332
[TBL] [Abstract][Full Text] [Related]
9. Tumor interstitial fluid - a treasure trove of cancer biomarkers.
Gromov P; Gromova I; Olsen CJ; Timmermans-Wielenga V; Talman ML; Serizawa RR; Moreira JM
Biochim Biophys Acta; 2013 Nov; 1834(11):2259-70. PubMed ID: 23416532
[TBL] [Abstract][Full Text] [Related]
10. Clinical Proteomics of Biofluids in Haematological Malignancies.
Dunphy K; O'Mahoney K; Dowling P; O'Gorman P; Bazou D
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360786
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers.
Abyadeh M; Meyfour A; Gupta V; Zabet Moghaddam M; Fitzhenry MJ; Shahbazian S; Hosseini Salekdeh G; Mirzaei M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198323
[TBL] [Abstract][Full Text] [Related]
12. One Sample, One Shot - Evaluation of sample preparation protocols for the mass spectrometric proteome analysis of human bile fluid without extensive fractionation.
Megger DA; Padden J; Rosowski K; Uszkoreit J; Bracht T; Eisenacher M; Gerges C; Neuhaus H; Schumacher B; Schlaak JF; Sitek B
J Proteomics; 2017 Feb; 154():13-21. PubMed ID: 27932303
[TBL] [Abstract][Full Text] [Related]
13. Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery.
Krüger T; Lautenschläger J; Grosskreutz J; Rhode H
Proteomics Clin Appl; 2013 Jan; 7(1-2):123-35. PubMed ID: 23129563
[TBL] [Abstract][Full Text] [Related]
14. Mining the malignant ascites proteome for pancreatic cancer biomarkers.
Kosanam H; Makawita S; Judd B; Newman A; Diamandis EP
Proteomics; 2011 Dec; 11(23):4551-8. PubMed ID: 21932441
[TBL] [Abstract][Full Text] [Related]
15. Towards defining biomarkers indicating resistances to targeted therapies.
Stehle F; Schulz K; Seliger B
Biochim Biophys Acta; 2014 May; 1844(5):909-16. PubMed ID: 24269379
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
[TBL] [Abstract][Full Text] [Related]
17. Advances in proximal fluid proteomics for disease biomarker discovery.
Teng PN; Bateman NW; Hood BL; Conrads TP
J Proteome Res; 2010 Dec; 9(12):6091-100. PubMed ID: 21028795
[TBL] [Abstract][Full Text] [Related]
18. Proteomic applications for the early detection of cancer.
Wulfkuhle JD; Liotta LA; Petricoin EF
Nat Rev Cancer; 2003 Apr; 3(4):267-75. PubMed ID: 12671665
[TBL] [Abstract][Full Text] [Related]
19. Body fluid peptide and protein signatures in diabetic kidney diseases.
Jankowski J; Schanstra JP; Mischak H
Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv43-53. PubMed ID: 26209737
[TBL] [Abstract][Full Text] [Related]
20. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
